Recently, several studies have investigated the relationship between diabetes and hearing impairment, but results were inconsistent.
to hear lower than normal voices and may cause individuals to miss parts or all of words in ordinary communication. Epidemiologically, several health problems in relation to hearing impairment have been reported such as depression (4) and dementia (5). Lin et al. (5) reported that the risks of all-cause dementia and Alzheimer's disease for a 10-dB hearing impairment increase by 27 and 20%, respectively.
Hearing impairment has many causes. The most common is presbycusis, followed by noise exposure, ototoxic drugs, and viral infections (4) . In addition to these factors, the association of hearing impairment with diabetes is controversial (http://www.nature.com/ news/2004/040227/full/news040223-12.html) (7) . It is believed that, over time, high blood glucose levels can damage the vessels in the stria vascularis and nerves, diminishing the ability to hear (8) . However, there is insufficient evidence of a significant relationship between diabetes and hearing impairment from the epidemiological viewpoint. Therefore, we aimed to compare the prevalence of hearing impairment between diabetic and nondiabetic adults.
Materials and Methods

Search strategy
The meta-analysis was conducted according to the checklist of the Meta-analysis of Observational Studies in Epidemiology (9) . b Each diabetic subject was matched with a nondiabetic subject for age and gender.
c Subjects exposed to noisy environments were excluded.
We used an electronic literature search engine, EMBASE.com, which makes it possible to search the MEDLINE (1950 to May 30, 2011) and EMBASE (1974 to May 30, 2011) databases simultaneously, to identify articles examining the relationship between diabetes and the prevalence of hearing impairment. We added a manual search using the reference lists of the relevant articles. No language restriction was imposed. Two search themes were combined using the Boolean operator, and the first keywords were related to hearing impairment using hearing disorder, hearing impairment, hearing loss, hypoacusis, monaural hearing, perception deadness, unilateral hearing loss, hearing, deaf, and deafness as EMTREE terms, and hearing disorder, hearing impairment, hearing loss, deaf, deafness, hearing damage, hearing defect, hearing difficulty, and impaired hearing as text words. The second keywords were related to diabetes. Diabetes and diabetic were used as EMTREE terms corresponding to MeSH terms in MEDLINE, and diabetes mellitus, diabetes, and diabetic as text words.
Inclusion and exclusion criteria
The study inclusion criteria were as follows: 1) observational study using a cross-sectional design, 2) adult subjects targeted, 3) data given on the number of hearing-impaired and non-hearingimpaired cases in the presence of diabetes, and 4) hearing impairment objectively assessed using pure-tone audiometry that included a frequency range of at least 2 kHz.
We focused on studies using a cross-sectional design because there has been only one prospective study on this topic (10) . We considered hearing impairment in this meta-analysis as chronic, progressive, or sensorineural and without specific cause [e.g. noise or heredity (11) (12) (13) or Wolfram syndrome (14) ]. The most updated article was selected if multiple articles were published for the same population. We included studies that examined the prevalence of hearing impairment based on both the best and worst ear. However, if a study presented both unilateral and bilateral data on hearing impairment, priority was given to data on hearing impairment in the better ear (i.e. bilateral ear) to maintain consistency with the criteria of hearing impairment by the WHO as much as possible.
Data abstraction
We extracted the following data from each publication: first author's name, year of publication, number of total and hearingimpaired participants, mean or range of age, proportion of males, geographic region, whether hearing loss was unilateral or bilateral, surveyed frequency range, and definition of hearing loss for each study.
We assessed study quality by the presence of the following items: 1) identification of the type of diabetes, 2) description of the mean duration of diabetes, 3) data given on the presence of diabetic macrovascular and microvascular complications, 4) diabetic and nondiabetic subjects matched for age and gender, 5) exclusion of subjects exposed to noisy environments. Two of our investigators (C.H. and S.K.) independently abstracted these data. Discrepancies were resolved by a third investigator (H.So.).
Data synthesis and analysis
The pooled odds ratio (OR) of hearing impairment in persons with diabetes compared with those without diabetes was calcu- lated with a random-effects model using the DerSimonian and Laird method (15) and using between-study heterogeneity derived from the Mantel-Haenszel model (16) . The extent of between-study heterogeneity was assessed by I-squared statistics (17) . To explore the origin of between-study heterogeneity, analyses were stratified by the following prespecified confounders that potentially influenced the study results: mean age (Ն60 or Ͻ60 yr), percentage of men (Ն50% or Ͻ50%), country (Asian or Western), origin of the study population (general or hospitalbased population), and criteria for detection of hearing impairment such as threshold (Ն25 dB or Ͻ25dB), frequency range (all or partial), and ear (bilateral or unilateral). Publication bias was statistically assessed by two formal methods: by Begg's rank correlation and Egger's regression test (18, 19) . Two-sided P value Ͻ0.05 was considered as statistically significant except for the test for publication bias where P Ͻ 0.10 was used (20) . All analyses were conducted with Stata statistical software version 11 (Stata Corp., College Station, TX).
Results
Literature research and study characteristics Figure 1 shows details of the literature search. First, 3158 citations were identified. Of these, 2814 articles were excluded according to information given in the title and abstract, and 355 articles, including 11 articles obtained from the manual search, were included for a more detailed review. The review identified four articles (21) (22) (23) (24) that were based on overlapping data from the National Health and Nutrition Examination Survey (25), one article (26) that was based on overlapping data from the Blue Mountains Hearing Study (27) , and one article (28) that was based on overlapping data from the study of Marumo et al. (29) . We avoided duplicate inclusion of data by selecting only the more complete article from each study. Finally, 13 articles describing studies with a cross-sectional design met our initial inclusion criteria. A complete reference list of studies included in our meta-analysis is reported in the Supplemental Data.
Characteristics of the 13 selected studies comprising 20,194 participants (range, 100-7669) and 7377 cases (range, 46 -2077) of hearing impairment are shown in Table 1 . Twelve studies included both males and females (25, 27, 29, 30 -38) , and one study involved males only (39) . No study involved females only. In a large number of included studies (nine studies) (25, 29 -31, 33, 34, 36, 38, 39) , the mean age of participants was 60 yr or less. Eight studies (27, 30 -32, 34, 36, 38, 39) were of the Asian region and five studies (25, 33, 35, 37, 38) of non-Asian regions. In five studies (29, 30, 33, 36, 38) , participants were hospital based, and in eight studies (25, 27, 31, 32, 34, 35, 37, 39) , participants were from the general population. All studies described the method for assessment of hearing impairment. Most studies (10 studies) (25, 27, 29, 30 -32, 35-37, 39) used 25 dB for the hearing impairment threshold with the exception of three studies (33, 34, 38) that used 26, 30, and 20 dB, respectively, as the threshold. Therefore, in all of those included studies, the threshold levels were almost consistent with that of hearing impairment according to the WHO (3). Six studies surveyed unilateral hearing impairment only (25, 31, 35, (37) (38) (39) , and five surveyed bilateral hearing impairment only (27, 29, 33, 34, 36) . The remaining two studies included both unilateral and bilateral hearing impairment (30, 32) . In 10 studies, hearing impairment was declared if the disability was present at all frequency ranges, (25, 27, 30 -32, 34 -37, 39) , and in three studies, impairment was declared if the disability was observed in one or more frequencies (29, 33, 38) .
Nine of 13 studies (27, 29 -32, 34, 36, 37, 39) identified the type of diabetes. Six studies (27, 29, 34, 36, 37, 39) included only participants with type 2 diabetes, and three studies (29, 31, 32) included both type 1 diabetic and type 2 diabetic participants. Mean duration of diabetes was given in only four studies (25, 27, 30, 31) . No study described diabetic complications experienced by the subjects. In three studies (31, 34, 36) , each diabetic subject was matched with a nondiabetic subject for age and gender. In six studies (29, 31, 33, 34, 36, 38) , subjects exposed to noisy environments were excluded; however, no study matched diabetic subjects with nondiabetic subjects according to locations in which specific sources of noise exposure existed, such as industrial, farming, and urban areas.
Overall estimate of prevalence of hearing impairment associated with diabetes
Three studies consisted of two datasets; two (30, 31) analyzed bilateral and unilateral hearing impairment separately, and one (25) included two independent research studies. One study (32) was composed of four datasets based on both age bracket and symmetry of hearing impairment.
A total of 19 datasets were included in this meta-analysis. We used the data surveyed for unilateral hearing impairment (30 -32) when the results of the same study overlapped. Figure 2 shows the pooled estimates for hearing impairment in persons with diabetes. The overall pooled OR of hearing impairment for diabetic patients compared with the nondiabetic participants was 2.15 [95% confidence interval (CI) ϭ 1.72-2.68]. Between-study heterogeneity was highly significant in the strength of the association (I 2 ϭ 76.2%; P Ͻ 0.001). Only one study, that reported by Aladag et al. (34) , indicated the negative association between diabetes and hearing impairment risk. However, between-study heterogeneity after excluding this study remained highly significant (I 2 ϭ 76.0%; P Ͻ 0.001). Publication bias was not statistically detected by Egger's test (P ϭ 0.79) and Begg's test (P ϭ 0.54). Table 2 shows the results of the stratified and metaregression analyses across a number of key study characteristics to explore the origin of the heterogeneity and the influence of the characteristics on study results. A positive association between diabetes and prevalence of impaired hearing was consistently observed throughout all strata of the specified study characteristics. No significant difference in the strength of the association of diabetes with hearing impairment was observed according to whether hearing impairment was unilateral or bilateral [2.21 (95% CI ϭ 1.55-3.15) and 2.10 (95% CI ϭ 1.54 -2.87), P ϭ 0.85].
Stratified analysis
A statistically stronger association between hearing impairment and diabetes incidence was observed in the younger participants (mean age of participants, Յ60 yr) in comparison with those over 60 yr, and the difference was statistically significant [2.61 (95% CI ϭ 2.00 -3.45) and 1.58 (95% CI ϭ 1.38 -1.81), P ϭ 0.008]. Studies comprised of hospital-based populations reported a significantly stronger association than those studies of the general population [3.56 (95% CI ϭ 2.51-5.05) and 1.90 (95% CI ϭ 1.51-2.41), P ϭ 0.05]. When the study that defined the threshold of hearing impairment as more than 25 dB was excluded, the pooled risk of hearing impairment was 2.08 (95% CI ϭ 1.65-2.62), but the influence of the exclusion was not significant (P ϭ 0.35). The strength of the association between diabetes and hearing impairment was not influenced by differences in the region that the study took place (P ϭ 0.21), threshold for hearing impairment (P ϭ 0.35), impaired frequency range (P ϭ 0.34), whether diabetes was specified as type 2 (P ϭ 0.49), whether diabetic participants and nondiabetic participants were matched for age and sex (P ϭ 0.68), and whether subjects exposed to noisy environments were excluded (P ϭ 0.19).
Discussion
The current meta-analysis indicated that hearing impairment in subjects with diabetes was 2.1-fold more prevalent than in those without diabetes. The significant association between hearing impairment and diabetes was maintained throughout several subgroup-stratified analyses.
Especially, it is well known that aging is associated with both prevalence of hearing impairment and diabetes. Therefore, it is possible that the observed significant relationship between hearing impairment and diabetes is merely a phenomenon of aging. However, according to the stratified analyses, a stronger association was observed in studies of younger participants (mean age of participants, Յ60 yr) compared with studies of older participants. Nevertheless, the OR remained significant when studies were limited to those with participants having a mean age over 60 yr. In addition, a nonsignificant but larger OR was observed in age-matched studies compared with those not age matched, although there were only three studies in which participants were age matched. Our results suggest an independent association of hearing impairment and diabetes, although the possibility of residual confounding by age cannot be eliminated.
A meta-analysis of observational studies in principle can never prove causality. However, there is a plausible explanation of why diabetes could lead to progression of hearing impairment. Fukushima et al. (8) reported that thickened walls of vessels in the stria vascularis and their atrophy were observed in patients treated with insulin or hyperglycemic agents compared with those in healthy subjects. It will be important to clarify the dose-response association between the severity of diabetes and risk of hearing impairment (i.e. the relationship between hyperglycemia, duration of diabetes, and the prevalence of hearing impairment) for elucidating the causality between hearing impairment and diabetes mellitus. Furthermore, the significance of strict glycemic control in the prevention of hearing loss should be studied.
Limitations of this meta-analysis must be considered. First, our meta-analysis is based on findings of observational studies; therefore, it is impossible to control residual confounders linking diabetes and hearing impairment (e.g. drug use) (6) . Second no data were provided on the prevalence of diabetic complications in any of the included studies. Given that microangiopathy in the inner ear was suggested in patients with diabetes (8), it is possible that the severity of diabetes might influence the strength of the association between diabetes and hearing impairment and produce between-study heterogeneity in the association. That possibility might have been reflected by the result of the stratified analysis that showed a stronger association in hospital-based populations that included patients with severe diabetes compared with studies of general populations.
Third, we limited our analysis to adult-onset hearing impairment. However, persons with hearing impairment before adulthood might have been included among subjects in this meta-analysis. For example, it is possible that patients with diabetic cheiropathy developed asymptomatic hearing impairment before adulthood, although there has been no report showing clear evidence for the coexistence of hearing impairment among such patients.
Fourth, there were no studies that matched diabetic individuals and nondiabetic individuals in locations where sources of noise exposure were similar. Therefore, the extent of noise exposure might have been different between diabetic and nondiabetic subjects. However, noise exposure is unlikely to be a confounder because the current stratified analysis indicated that the strength of association between diabetes and prevalence of hearing impairment was not significantly influenced by whether or not subjects who were chronically exposed to a noisy environment were excluded.
Finally, publication bias is inevitable because researchers are not as likely to report negative findings. Its possibility could not be ruled out even if it were not statistically derived. Except for the top characteristic, assessed ear, data based on the better ear were used if both the better and worst ear were assessed. a Represents the test for the significance of the study modification across strata.
In conclusion, our meta-analysis indicated a significantly higher prevalence of hearing impairment in patients with diabetes compared with that in nondiabetic people. Moreover, the finding is likely to be independent of the effect of aging or a noisy environment. Additional studies are needed to clarify the relationship between diabetes severity and prevalence of hearing impairment and the effect of glycemic control on hearing loss.
